Baixin Shen

691 total citations
36 papers, 522 citations indexed

About

Baixin Shen is a scholar working on Urology, Molecular Biology and Rheumatology. According to data from OpenAlex, Baixin Shen has authored 36 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Urology, 10 papers in Molecular Biology and 9 papers in Rheumatology. Recurrent topics in Baixin Shen's work include Urinary Bladder and Prostate Research (14 papers), Pelvic floor disorders treatments (7 papers) and Urinary Tract Infections Management (6 papers). Baixin Shen is often cited by papers focused on Urinary Bladder and Prostate Research (14 papers), Pelvic floor disorders treatments (7 papers) and Urinary Tract Infections Management (6 papers). Baixin Shen collaborates with scholars based in China, United States and Israel. Baixin Shen's co-authors include H. Henry Lai, Joel Vetter, Zhongqing Wei, Liucheng Ding, Jun Xue, Chao Qin, Min Tang, Wei Zhang, Chengdi Yang and Zhiqiang Qin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The Journal of Urology.

In The Last Decade

Baixin Shen

34 papers receiving 518 citations

Peers

Baixin Shen

UROLO

RHEUM

EPIDE

SURGE

Hakkı Perk Türkiye

Zhezhu Gao China

Hanumanthappa Nandeesha India

Fábio Henrique Silva Brazil

Ming-Kuen Lai Taiwan

Maryam Razzaghy‐Azar Iran

Mutsumi Murakami Japan

Yat-Ching Tong Taiwan

Mi-Hye Kwon South Korea

Hicham Labazi United States

Hakkı Perk Türkiye

Baixin Shen

87 ×0.5

UROLO

66 ×0.4

RHEUM

83 ×0.5

40 ×0.4

EPIDE

93 ×1.6

SURGE

Citations per year, relative to Baixin Shen Baixin Shen (= 1×) peers Hakkı Perk

Countries citing papers authored by Baixin Shen

Since Specialization

Citations

This map shows the geographic impact of Baixin Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baixin Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baixin Shen more than expected).

Fields of papers citing papers by Baixin Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baixin Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baixin Shen. The network helps show where Baixin Shen may publish in the future.

Co-authorship network of co-authors of Baixin Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Baixin Shen. A scholar is included among the top collaborators of Baixin Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baixin Shen. Baixin Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Junqi, et al.. (2025). Rictor Ameliorates Acute Antibody‐Mediated Rejection Following Kidney Transplantation by Suppressing Macrophage M1 Polarization Through p65‐NLRP3 Axis. Advanced Science. 12(34). e17119–e17119.

Chen, Kaiyang, Hangjin Jiang, Shuting Zhang, et al.. (2024). Leveraging Random Effects in Cistrome‐Wide Association Studies for Decoding the Genetic Determinants of Prostate Cancer. Advanced Science. 11(36). e2400815–e2400815. 3 indexed citations

Xu, Hewei, Weilong Li, Junjie Zhang, et al.. (2023). Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis. Frontiers in Oncology. 13. 1067987–1067987.

Liu, Yu, et al.. (2022). Echinacoside Ameliorates Cyclophosphamide-Induced Bladder Damage in Mice. Journal of Medicinal Food. 25(7). 722–731. 6 indexed citations

Liao, Limin, Guoqing Chen, Zhihui Xu, et al.. (2022). Sacral Neuromodulation Using a Novel Device with a Six–contact-point Electrode for the Treatment of Patients with Refractory Overactive Bladder: A Multicenter, Randomized, Single-blind, Parallel-control Clinical Trial. European Urology Focus. 8(6). 1823–1830. 5 indexed citations

Shen, Baixin, et al.. (2022). Medium-term Clinical Efficacy and Complications of Plasmakinetic Enucleation of the Prostate Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia. Urology. 164. 204–210. 2 indexed citations

Xu, Hewei, et al.. (2022). Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 12. 906370–906370. 8 indexed citations

Wei, Zhongqing, et al.. (2021). Nrf2 Pathway Ameliorates Bladder Dysfunction in Cyclophosphamide‐Induced Cystitis via Suppression of Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2021(1). 4009308–4009308. 19 indexed citations

Liu, Yadong, et al.. (2021). CGRP protects bladder smooth muscle cells stimulated by high glucose through inhibiting p38 MAPK pathway in vitro. Scientific Reports. 11(1). 7643–7643. 3 indexed citations

10.

Shen, Baixin, et al.. (2021). Management and Follow-Up Practices of Women With Recurrent Stress Urinary Incontinence Following Transobturator Mid-urethral Synthetic Sling Procedure: A 6-Year Retrospective Monocentric University-Based Study. Frontiers in Surgery. 8. 710594–710594. 2 indexed citations

11.

Xu, Hewei, Jie Gao, Jie Xu, et al.. (2021). Combined Signature of the Urinary Microbiome and Metabolome in Patients With Interstitial Cystitis. Frontiers in Cellular and Infection Microbiology. 11. 711746–711746. 19 indexed citations

12.

Xu, Hewei, et al.. (2020). Primary bladder mucosa-associated lymphoid tissue lymphoma. Medicine. 99(28). e20825–e20825. 8 indexed citations

13.

Gao, Jie, et al.. (2020). Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model. Stem Cell Research & Therapy. 11(1). 278–278. 8 indexed citations

14.

Luo, Dan, et al.. (2017). [The effect of tanshinone ⅡA potentiates the effects of Cisplatin in Fadu cells in vitro through downregulation of survivin].. PubMed. 31(10). 781–784. 4 indexed citations

15.

Ding, Liucheng, et al.. (2017). Integrin-Linked Kinase Improves Functional Recovery of Diabetic Cystopathy and Mesenchymal Stem Cell Survival and Engraftment in Rats. Canadian Journal of Diabetes. 41(3). 312–321. 4 indexed citations

16.

Tang, Jinyuan, et al.. (2017). Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma. Experimental and Therapeutic Medicine. 14(4). 3221–3228. 1 indexed citations

17.

Qin, Zhiqiang, Zhen Xu, Ran Li, et al.. (2017). RTA‐408 Protects Kidney from Ischemia‐Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene. Oxidative Medicine and Cellular Longevity. 2017(1). 7612182–7612182. 58 indexed citations

18.

Shen, Hua, et al.. (2013). Differential expression of peroxiredoxin 6, annexin A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1 in testis of rat fetuses after maternal exposure to di-n-butyl phthalate. Reproductive Toxicology. 39. 76–84. 8 indexed citations

19.

Ding, Guanxiong, Fang Liu, Baixin Shen, et al.. (2012). The Association Between Polymorphisms in Prooxidant or Antioxidant Enzymes (Myeloperoxidase, SOD2, and CAT) and Genes and Prostate Cancer Risk in the Chinese Population of Han Nationality. Clinical Genitourinary Cancer. 10(4). 251–255. 17 indexed citations

20.

Zhang, Wei, et al.. (2007). Differential expression of peroxiredoxin 6 in fetal rat testis following in utero exposure to di(nbutyl) phthalate. Toxicology. 240(1-2). 86–95. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact